FDA Recalls Deferasirox Tablets for Failed Dissolution Specifications
Glenmark Pharmaceuticals is recalling Deferasirox 500mg tablets nationwide due to failed dissolution specifications affecting approximately 5,856 bottles across multiple lots.
- Product
- DEFERASIROX — DEFERASIROX (DEFERASIROX)
- Category
- Drug
- Distribution
- Distributed nationwide